Anika Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 12 of 12 Posts
The Week Ahead In Biotech: Pharma Earnings Pick Up Pace
Article By: Benzinga Saturday, July 20, 2019 8:56 PM EDT
Biotech stocks had a relatively muted performance last week. Johnson & Johnson kickstarted the second-quarter reporting season for big pharma companies, beating forecasts and an upward adjustment to its full-year sales guidance.
In this article: BMY, DGX, EW, JNJ, MRK, ANIK, BIIB, CELG, BHVN
Read
4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings
Article By: Arpita Dutt Monday, July 17, 2017 11:35 AM EDT
Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson reporting second quarter results tomorrow before the market opens.
In this article: VRX, FLXN, RXDX, ANIK Also: JNJ, NVS
Read
Anika Therapeutics Offers A Long-Term Growth Opportunity With Robust Pipeline
Article By: KKD Healthcare Analytics Wednesday, July 5, 2017 10:43 AM EDT
Anika Therapeutics has relatively mild risk profile. The company has established products in the market while its drug candidates have high probability of receiving the FDA approval as well as of performing well in the market.
In this article: ANIK
Read
Is Economic Growth Slowing – Is This Bull Market About To End?
Article By: Robert Maltbie Saturday, May 13, 2017 6:51 PM EDT
US economic growth was expected to improve in 2017 but the initial release of the first quarter GDP was less than stellar. And bond yields declined recently – is this a forewarning of a weaker economy and what are the impacts on the equity markets?
In this article: SA, ARTX, GASS, HBIO, IRIX, LABL, STMP, ANIK, CNTY, CTRL
Read
Trend Following Watch List Stocks For This Coming Week
Article By: Andy Abraham Monday, July 4, 2016 3:20 AM EDT
Every weekend I compile a list of stocks worth watching in my "trend following". However you need to make your own judgement and risk calculations.
In this article: AHS, COR, NSP, TDG, TRRU, STS, ALGN, SIMO, ANIK, BECN, NTES, NVDA, POOL, ULTA, WB, GIMO, PAYC, FCPT, FIVE
Read
GlaxoSmithKline Q1 Earnings Lag, Revenues Up Y/Y
Article By: Zacks Investment Research Thursday, April 28, 2016 8:30 PM EDT
GlaxoSmithKline PLC reported first-quarter 2016 core earnings of 57 cents per American Depositary Share (ADS), missing the Zacks Consensus Estimate of 60 cents. Nevertheless, the company’s shares inched up 1.8% following the news.
In this article: EBS, GSK, NVS, ANIK
Read
Top 5 Stocks With Increasing Cash Flows
Article By: Zacks Investment Research Tuesday, April 26, 2016 4:39 AM EDT
While in the heart of the first-quarter earnings season, investors might find it easy to look for profits and surprises to scoop up big gains.
In this article: EBS, FOR, JBT, ANIK, NSAT
Read
E Small Cap Best & Worst Stocks - March 31, 2016
Article By: E.B. Capital Markets Thursday, March 31, 2016 8:18 AM EDT
The average small cap score is 51.16 and that's below the four week average score of 52.54.
In this article: BYD, ELLI, MOV, STRI, ABMD, DWSN, INFI, NVAX, REDF, ANIK, CCRN, FRAN, OFIX, SONC, MTSI
Read
5 Stocks To Gain From Medical Device Excise Tax Exemption
Article By: Zacks Investment Research Friday, March 11, 2016 5:34 AM EDT
The temporary suspension of the medical device excise tax albeit for two years should encourage investors to make the most out of the MedTech industry, even as the stock market reels under the pressure of a pessimistic wave.
In this article: CRY, ANIK, CPSI, OFIX, NVTA
Read
Magic Formula Investing Weekly Roundup 2/22/2015
Article By: Steve Alexander Monday, February 23, 2015 12:01 AM EDT
There was a fair bit of movement in the Magic Formula screens this week, although practically all of these stocks have been in-and-out of the screens over the past several months.
In this article: SYNT, XLNX, KING, GIB, CHE, GPS, PTIE, ITRN, DHX, ANIK, COH
Read
Taking Stock Of The New Normal: Mark Landy On New Growth Ideas For Biotech Investors
Article By: The Life Sciences Report Friday, August 8, 2014 6:06 PM EDT
Medical technology is intimately linked to regenerative medicine. You could say these industries have a thunder-and-lightning relationship.
In this article: JNJ, ANIK, HART
Read
E Small Cap Report
Article By: E.B. Capital Markets Thursday, March 20, 2014 1:39 PM EDT
The highest scoring names in small cap from 1 year ago (3/20/2013) returned 3,708 bps more than the S&P 500. The best performers have been RAD up 255%, CAMP up 205%, JAZZ up 163%, MDSO up 127%, GBX up 109%, and HOMB up 90%.
In this article: CDI, CGX, CHE, CMO, CWT, EXAM, FSS, GBX, GTS, PGI, RAD, STRI, WWE, AFFY, ALIM, ANAC, BABY, CYBX, DXPE, DXYN, ECOL, FLDM, GERN, HOMB, HTWR, IRWD, IVAC, JAZZ, MDSO, MPWR, NLNK, PENX, PHMD, REDF, RTIX, SABA, SGMO, SILC, SNTA, VASC, AGYS, AMED, ANIK, BJRI, BLDR, CAMP, CENX, CFNL, DIOD, ELNK, FINL, FORM, GLRE, LCAV, SNHY, STFC, TQNT, UEIC, UNTD, WIRE, XRTX, EBIX, KERX
Read
1 to 12 of 12 Posts